Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16574899rdf:typepubmed:Citationlld:pubmed
pubmed-article:16574899lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:16574899lifeskim:mentionsumls-concept:C0003842lld:lifeskim
pubmed-article:16574899lifeskim:mentionsumls-concept:C1948058lld:lifeskim
pubmed-article:16574899lifeskim:mentionsumls-concept:C0020443lld:lifeskim
pubmed-article:16574899lifeskim:mentionsumls-concept:C0020456lld:lifeskim
pubmed-article:16574899lifeskim:mentionsumls-concept:C0021655lld:lifeskim
pubmed-article:16574899lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:16574899lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:16574899pubmed:issue6lld:pubmed
pubmed-article:16574899pubmed:dateCreated2006-5-19lld:pubmed
pubmed-article:16574899pubmed:abstractTextCollateral artery development (arteriogenesis), a vital compensatory mechanism in patients with arterial obstructive disease, may be deregulated by vascular risk factors, eg, diabetes or hypercholesterolemia. Here, we compared the effects of either disturbed glucose metabolism or disturbed lipid metabolism on arteriogenesis.lld:pubmed
pubmed-article:16574899pubmed:languageenglld:pubmed
pubmed-article:16574899pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16574899pubmed:citationSubsetIMlld:pubmed
pubmed-article:16574899pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16574899pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16574899pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16574899pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16574899pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16574899pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16574899pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16574899pubmed:statusMEDLINElld:pubmed
pubmed-article:16574899pubmed:monthJunlld:pubmed
pubmed-article:16574899pubmed:issn1524-4636lld:pubmed
pubmed-article:16574899pubmed:authorpubmed-author:van BockelJ...lld:pubmed
pubmed-article:16574899pubmed:authorpubmed-author:QuaxPaul H...lld:pubmed
pubmed-article:16574899pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:16574899pubmed:authorpubmed-author:VosholPeter...lld:pubmed
pubmed-article:16574899pubmed:authorpubmed-author:EilersPaul...lld:pubmed
pubmed-article:16574899pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:16574899pubmed:authorpubmed-author:VerloopRobert...lld:pubmed
pubmed-article:16574899pubmed:authorpubmed-author:de...lld:pubmed
pubmed-article:16574899pubmed:issnTypeElectroniclld:pubmed
pubmed-article:16574899pubmed:volume26lld:pubmed
pubmed-article:16574899pubmed:ownerNLMlld:pubmed
pubmed-article:16574899pubmed:authorsCompleteYlld:pubmed
pubmed-article:16574899pubmed:pagination1383-90lld:pubmed
pubmed-article:16574899pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:16574899pubmed:meshHeadingpubmed-meshheading:16574899...lld:pubmed
pubmed-article:16574899pubmed:meshHeadingpubmed-meshheading:16574899...lld:pubmed
pubmed-article:16574899pubmed:meshHeadingpubmed-meshheading:16574899...lld:pubmed
pubmed-article:16574899pubmed:meshHeadingpubmed-meshheading:16574899...lld:pubmed
pubmed-article:16574899pubmed:meshHeadingpubmed-meshheading:16574899...lld:pubmed
pubmed-article:16574899pubmed:meshHeadingpubmed-meshheading:16574899...lld:pubmed
pubmed-article:16574899pubmed:meshHeadingpubmed-meshheading:16574899...lld:pubmed
pubmed-article:16574899pubmed:meshHeadingpubmed-meshheading:16574899...lld:pubmed
pubmed-article:16574899pubmed:meshHeadingpubmed-meshheading:16574899...lld:pubmed
pubmed-article:16574899pubmed:meshHeadingpubmed-meshheading:16574899...lld:pubmed
pubmed-article:16574899pubmed:meshHeadingpubmed-meshheading:16574899...lld:pubmed
pubmed-article:16574899pubmed:meshHeadingpubmed-meshheading:16574899...lld:pubmed
pubmed-article:16574899pubmed:meshHeadingpubmed-meshheading:16574899...lld:pubmed
pubmed-article:16574899pubmed:meshHeadingpubmed-meshheading:16574899...lld:pubmed
pubmed-article:16574899pubmed:meshHeadingpubmed-meshheading:16574899...lld:pubmed
pubmed-article:16574899pubmed:meshHeadingpubmed-meshheading:16574899...lld:pubmed
pubmed-article:16574899pubmed:meshHeadingpubmed-meshheading:16574899...lld:pubmed
pubmed-article:16574899pubmed:meshHeadingpubmed-meshheading:16574899...lld:pubmed
pubmed-article:16574899pubmed:meshHeadingpubmed-meshheading:16574899...lld:pubmed
pubmed-article:16574899pubmed:meshHeadingpubmed-meshheading:16574899...lld:pubmed
pubmed-article:16574899pubmed:meshHeadingpubmed-meshheading:16574899...lld:pubmed
pubmed-article:16574899pubmed:year2006lld:pubmed
pubmed-article:16574899pubmed:articleTitleHypercholesterolemia reduces collateral artery growth more dominantly than hyperglycemia or insulin resistance in mice.lld:pubmed
pubmed-article:16574899pubmed:affiliationGaubius Laboratory TNO Biomedical Research, Leiden, The Netherlands.lld:pubmed
pubmed-article:16574899pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16574899pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:16574899pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16574899lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16574899lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16574899lld:pubmed